Profile data is unavailable for this security.
About the company
Mettler-Toledo International Inc. is a supplier of precision instruments and services. The Company manufactures a variety of precision instruments and provides value-added services to its customers. Its principal products and services include laboratory instruments, industrial instruments, and retail weighing solutions. It has a variety of precision laboratory instruments for sample preparation, synthesis, analytical bench top, material characterization, and in-line measurement. Its laboratory instrument portfolio includes laboratory balances, liquid pipetting solutions, automated laboratory reactors, including real time analytics, titrators, pH meters, and other instruments. It manufactures numerous industrial weighing instruments and related terminals, and offers software solutions for the pharmaceutical, chemical, food, discrete manufacturing, and other industries. It offers weighing and software solutions, which can integrate counter, self-service, backroom and checkout functions.
- Revenue in USD (TTM)3.75bn
- Net income in USD785.75m
- Incorporated1991
- Employees16.00k
- LocationMettler-Toledo International Inc1900 Polaris PkwyCOLUMBUS 43240-4035United StatesUSA
- Phone+1 (614) 438-4511
- Fax+1 (302) 655-5049
- Websitehttps://www.mt.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hologic Inc | 3.99bn | 701.50m | 18.90bn | 6.99k | 27.77 | 3.81 | 18.69 | 4.74 | 2.93 | 2.93 | 16.59 | 21.33 | 0.4375 | 2.64 | 6.06 | 570,472.10 | 7.70 | 11.40 | 8.64 | 13.38 | 55.41 | 60.29 | 17.59 | 20.95 | 3.32 | 709.77 | 0.3408 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
Baxter International Inc | 15.00bn | -157.00m | 19.64bn | 60.00k | -- | 2.57 | 17.69 | 1.31 | -0.3066 | 4.87 | 29.48 | 14.98 | 0.5534 | 3.24 | 5.73 | 249,950.00 | -0.5462 | 0.1942 | -0.7019 | 0.2333 | 36.48 | 38.20 | -0.9869 | 0.3674 | 0.9147 | 4.25 | 0.626 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
Waters Corp | 2.88bn | 595.69m | 19.98bn | 7.90k | 33.53 | 14.15 | 25.37 | 6.95 | 10.04 | 10.04 | 48.46 | 23.79 | 0.6394 | 2.19 | 4.41 | 364,118.20 | 13.24 | 19.77 | 16.04 | 25.29 | 59.68 | 58.45 | 20.71 | 23.38 | 1.42 | 8.74 | 0.5869 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
Illumina Inc | 4.43bn | -3.04bn | 20.90bn | 10.59k | -- | 14.53 | -- | 4.72 | -19.18 | -19.18 | 27.94 | 9.03 | 0.4961 | 2.86 | 6.26 | 418,224.80 | -34.09 | -6.20 | -45.61 | -7.28 | 62.00 | 66.39 | -68.71 | -15.48 | 0.8596 | 14.07 | 0.6087 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
Zimmer Biomet Holdings Inc | 7.52bn | 997.10m | 21.67bn | 18.00k | 22.18 | 1.71 | 11.04 | 2.88 | 4.80 | 4.80 | 36.22 | 62.18 | 0.3515 | 0.9141 | 5.40 | 418,050.00 | 4.66 | 2.21 | 5.40 | 2.52 | 71.78 | 71.25 | 13.27 | 7.28 | 0.629 | 7.51 | 0.314 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
Cooper Companies Inc | 3.80bn | 359.30m | 22.00bn | 15.00k | 61.53 | 2.78 | 29.89 | 5.78 | 1.80 | 1.80 | 19.02 | 39.80 | 0.3196 | 1.70 | 5.56 | 253,606.70 | 3.02 | 10.06 | 3.29 | 11.34 | 66.36 | 65.54 | 9.45 | 29.00 | 1.18 | 5.46 | 0.2493 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
West Pharmaceutical Services Inc. | 2.88bn | 524.90m | 22.35bn | 10.60k | 43.78 | 8.68 | 34.12 | 7.77 | 7.04 | 7.04 | 38.62 | 35.49 | 0.8037 | 4.26 | 5.68 | 271,405.70 | 14.22 | 15.61 | 16.93 | 18.65 | 35.69 | 38.06 | 17.70 | 18.47 | 1.68 | -- | 0.0751 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
Steris PLC | 5.13bn | 567.70m | 23.37bn | 18.18k | 41.42 | 3.68 | 21.06 | 4.55 | 5.72 | 4.03 | 51.73 | 64.32 | 0.4914 | 3.98 | 5.77 | 282,395.10 | 5.45 | 5.19 | 5.95 | 5.68 | 43.19 | 43.64 | 11.09 | 10.97 | 1.49 | 7.03 | 0.2666 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
DexCom Inc | 3.93bn | 666.90m | 28.22bn | 9.60k | 44.21 | 11.59 | 32.36 | 7.17 | 1.59 | 1.59 | 9.38 | 6.08 | 0.5778 | 2.92 | 4.64 | 409,875.00 | 9.79 | 8.30 | 13.57 | 10.50 | 63.16 | 65.90 | 16.95 | 14.14 | 2.48 | -- | 0.5063 | 0.00 | 24.49 | 28.56 | 58.70 | -- | 28.66 | -- |
Mettler-Toledo International Inc | 3.75bn | 785.75m | 29.84bn | 16.00k | 38.69 | -- | 32.85 | 7.96 | 36.34 | 36.34 | 173.40 | -7.20 | 1.13 | 4.01 | 5.85 | 234,384.60 | 23.74 | 23.32 | 36.29 | 34.02 | 59.33 | 58.58 | 20.95 | 20.51 | 0.6337 | 13.58 | 1.08 | 0.00 | -3.35 | 5.23 | -9.60 | 8.85 | -5.90 | -- |
Veeva Systems Inc | 2.57bn | 615.26m | 34.80bn | 7.17k | 55.75 | 6.71 | 53.39 | 13.52 | 3.85 | 3.85 | 15.69 | 32.04 | 0.4453 | -- | 6.27 | 358,846.80 | 10.65 | 11.97 | 12.97 | 15.36 | 73.35 | 72.00 | 23.91 | 23.74 | -- | -- | 0.00 | 0.00 | 9.68 | 22.35 | 7.79 | 18.00 | 21.68 | -- |
Resmed Inc | 4.69bn | 1.02bn | 35.99bn | 9.98k | 35.39 | 7.40 | 30.05 | 7.68 | 6.92 | 6.92 | 31.76 | 33.11 | 0.6878 | 2.23 | 5.81 | 469,468.60 | 14.99 | 14.24 | 17.08 | 16.53 | 56.67 | 56.85 | 21.79 | 20.35 | 1.69 | 27.20 | 0.1269 | 32.62 | 10.95 | 12.44 | 13.75 | 19.98 | 8.23 | 5.34 |
Agilent Technologies Inc | 6.50bn | 1.41bn | 40.25bn | 17.40k | 29.13 | 6.82 | 24.20 | 6.20 | 4.81 | 4.81 | 22.14 | 20.53 | 0.5996 | 2.87 | 5.06 | 358,950.30 | 13.04 | 11.00 | 16.13 | 13.25 | 54.75 | 53.29 | 21.75 | 18.01 | 1.37 | 55.86 | 0.3319 | 21.46 | -0.219 | 6.82 | -1.12 | 7.39 | 10.98 | 8.86 |
Edwards Lifesciences Corp | 5.75bn | 1.45bn | 40.26bn | 19.80k | 27.94 | 5.41 | 25.38 | 7.00 | 2.39 | 2.43 | 9.48 | 12.35 | 0.6018 | 1.29 | 7.50 | 290,292.90 | 15.14 | 16.63 | 17.44 | 19.12 | 77.58 | 76.71 | 25.17 | 24.84 | 2.87 | -- | 0.0737 | 0.00 | 11.56 | 10.03 | -7.85 | 13.70 | 1.96 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 30 Jun 2024 | 2.42m | 11.32% |
BlackRock Fund Advisorsas of 30 Jun 2024 | 1.22m | 5.70% |
Capital Research & Management Co. (International Investors)as of 30 Jun 2024 | 1.06m | 4.97% |
SSgA Funds Management, Inc.as of 30 Jun 2024 | 945.64k | 4.43% |
Fundsmith LLPas of 30 Jun 2024 | 850.86k | 3.98% |
Geode Capital Management LLCas of 30 Jun 2024 | 543.27k | 2.54% |
AllianceBernstein LPas of 30 Jun 2024 | 501.89k | 2.35% |
Walter Scott & Partners Ltd.as of 30 Jun 2024 | 417.63k | 1.96% |
Fiera Capital Corp. (Investment Management)as of 30 Jun 2024 | 372.99k | 1.75% |
T. Rowe Price Associates, Inc. (IM)as of 30 Jun 2024 | 317.37k | 1.49% |